.png)
Related Content
Download content relating to this event and topic.
3rd Clinical Trials Festival Asia 2025
#CTFA2025
Asia’s Foremost Clinical Trials Conference Uniting Clinical Trials Leaders
Join Clinical Trials Festival Asia 2025, connecting industry leaders to explore innovations in clinical research across Asia.
Sands Expo & Convention Centre, Singapore
12
-
13
March 2025
00
Days
00
Hours
00
Mins
00
Secs
300
+
Attendees
150
+
Companies
30
+
Speakers
72
+
Networking Hours
8
+
Case Studies
About the Event
Join us at Clinical Trials Festival Asia 2025, the region's premier clinical research conference in its third year. Connect with industry leaders to explore innovations in trial design, management, and decentralized approaches, while discussing partnerships, regulations, and digital strategies. The event highlights Asia's growing role in clinical research, particularly in Singapore, South Korea, and Australia, offering valuable networking opportunities with diverse professionals to enhance trial efficiency across the region.
Agenda at a Glance
View the Key Themes for
Clinical Trials Festival Asia 2025
Day 1
- Advancement in APAC as The Global Clinical Trials Hub
- Clinical Trials Patients Recruitment & Engagement
- Transforming Clinical Trials through Biomarker Advancements
- Exploring Innovations in Medical Affairs and Immunology
- Asia Pacific Bioprocessing Excellence Awards 2025
Day 2
- Advancing Pre-Clinical Research : From Discovery to Clinical Trials
- De-Centralised and Multi-Centre Trials
- Roundtable Discussion : Drug Discovery and Development to Regulatory Approvals, Patient-Centric Care, and Beyond
- Oncology Clinical Trials : New Modalities and Industry Innovations
Ready to attend?
Register today to secure your ticket.
Speakers
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Nitu Sinha
Vice President & Head Pharmacovigilance
Mankind Pharma
India
Chris Chong
Senior Director Clinical Services
Novotech
Australia
Bableen Gambhir
Director of Business Development
Novotech
Australia
Christopher Levi
Executive Director Research and Innovation
Hunter New England Local Health District
Australia
Mark Parsons
Director of Academic and Industry Partnerships, Research and Innovation
Hunter New England Local Health District
Australia
Sook Wern Chua
Head of Operational Strategy
Scientia Clinical Research
Australia
Esra Isikgel
Chief Executive Officer
Fenix Group
APAC
Sze-Piaw Chin
Founder and CEO
Cytopeutics
Malaysia
Pramod Kashid
CEO
Expecto Health Science
Singapore
Indri Rooslamiati
Director, National Biomedical Genome Science Institute and Clinical Research Center (INA-CRC)
Ministry of Health
Indonesia
Jing Ping Yeo
Global Head, Project Operations
George Clinical
Australia
Prof. Murray Cairns
Founder and CEO, NHMRC Leadership Research Fellow
PolygenRx, University of Newcastle
Australia
Cheng Cai Tang
Director Clinical Pharmacology, Modeling and Simulation (CPMS)
Parexel International
Singapore
Sachin Narkhede
Senior Director Clinical Operations, Study Start-up APAC
ICON plc
Singapore
Satyajit Mohapatra
Director, Centre for Clinical Trials and Research
SRM MCH&RC, SRM IST
India
Jeffery Wong
Senior Director, Strategic Partnerships & Client Services
Nucleus Network
Australia
Pankaj Thakur
Senior General Manager- Head Clinical Trials Project Management, Clinical Development and Medical Affairs (CD&Ma)
Hetero Group of Pharmaceutical Companies
India
Wei Chen
Vice President, Pre-Clinical and Clinical R&D
Gan & Lee Pharmaceuticals
China
Tira Tan
Senior Consultant
National Cancer Center Singapore (NCCS)
Singapore
Suhail Ali
Vice President & Regional Head, APAC Clinical Delivery and Project Management
Icon PLC
Singapore
Romik Ghosh
Director Medical Affairs - Emerging Therapies, Medical Excellence & Scientific Compliance
Novo Nordisk
India
Michelle Dee
Director, AP Regional Field Medical Centre of Excellence, Global Scientific Content and Medical Information Lead
MSD
Singapore
Michael Winther
Senior Director, Target Discovery
Engine Bioscience
Singapore
Josemund Menezes
Managing Director, Head of APAC
Zymeworks Inc.
Singapore
Dr. Wei Chen
Vice President, Pre-Clinical and Clinical R&D
Gan & Lee Pharmaceuticals
China
Naveen Jain
Vice President, Biologics R&D
Panacea Biotec
India
Danny Soon
CEO of CCRI, Singapore Executive Director of SCRI, Interim Executive Director of ACTRIS
Consortium for Clinical Research and Innovation Singapore, Singapore Clinical Research Institute, Advanced Cell Therapy and Research Institute Singapore
Singapore
Chang Cai Tang
Director Clinical Pharmacology, Modeling and Simulation (CPMS)
Parexel International
Singapore
Asad Abu Bakar Ali
Director, Biomarkers and Data Analytics
MSD
Singapore
Apurba Mukherjee
Regional Head Medical Affairs, Japan, Australia/ NZ, Korea (JAK), Southeast Asia (SEA)
Astellas Pharma
Singapore
.jpeg)
Shubhadeep Sinha
Senior Vice President, Global Head- CD&MA
Hetero Group of Pharmaceutical Companies
India
Kunal Shah
Head, Project Management, & EARO Business Ops
Experimental Drug Development Centre (EDDC)
Singapore
Ivan Horak
Founder and CEO
Tikva Allocell
Singapore
Tam C. Nguyen
Deputy Director of Research
St. Vincent’s Hospital Melbourne
Australia
Registration
Choose a plan that fits your role, company, and industry.
SG & APAC Biopharma / Academic
SGD 1,895
Standard Rate (By 1st March 2024)
*THIS PRICING IS APPLICABLE TO:
Company profiles: Biopharma, BIG Pharmas, Academic & Research Institutes in SG and APACApplicable Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
For Companies Outside Singapore
Get StartedFor Singapore-Based Companies
Get startedNON-APAC Biopharma / Academic
SGD 2,395
Standard Rate (By 1st March 2024)
*THIS PRICING IS APPLICABLE TO:
Company profiles: Biopharma, International (Outside APAC) Academic & Research Institutes outside of APAC
Applicable Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
For Companies Outside Singapore
Get StartedFor Singapore-Based Companies
Get startedService or Solution Provider / Big Pharma
SGD 4,695
Standard Rate (By 1st March 2024)
*THIS PRICING IS APPLICABLE TO:
Company Profiles: Service & Solution Providers, International biopharma, Big Pharma, CDMO/CMOs, Academics and Research Institutes
For Companies Outside Singapore
Get StartedFor Singapore-Based Companies
Get startedRegistration
Register Your Interest
Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
Want to Speak at This Event?
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Platinum
No items found.
Gold
No items found.
Silver
No items found.
Bronze & Associate
.png)
Nucleus Network
Nucleus Network is Australia’s largest and only multi-site Phase 1 clinical research organisation and the only Clinical Pharmacology specialist globally with facilities in the USA and Australia. For over two decades, Nucleus Network has been conducting Phase 1 clinical trials for Biotechnology and Pharmaceutical Companies from across the globe, including China, Europe, Japan, South Korea, Taiwan and the USA. Recognized as Phase 1 clinical trial experts, we operate over 200 beds, and have overseen more than 1,000 trials, of which 50% are first-in-human. Our Australian Phase 1 facilities are in Melbourne and Brisbane, and our USA Phase 1 facility is in Minneapolis. All three clinics are strategically co-located within leading medical, research and biotech precincts; the Alfred Hospital in Melbourne, the Royal Brisbane and Women’s Hospital in Brisbane, and Medical Alley in Minneapolis. These precincts provide Nucleus Network with unique access to highly specialized ancillary services for the conduct of complex Phase 1 clinical trials. We have extensive experience in both biologic and small molecule products across most therapeutic areas. As early phase specialists, we offer first-in-human study expertise, as well as rapid start clinical pharmacology studies. We are Australia’s premier Phase 1 trial facility and are one of the very few specialized units capable of delivering patients for hepatic and renal clinical trials in the USA. Together with our clients, we are fulfilling our purpose of "Advancing medicine, improving lives."
Nucleus Network is Australia’s largest and only multi-site Phase 1 clinical research organisation and the only Clinical Pharmacology specialist globally with facilities in the USA and Australia.
For over two decades, Nucleus Network has been conducting Phase 1 clinical trials for Biotechnology and Pharmaceutical Companies from across the globe, including China, Europe, Japan, South Korea, Taiwan and the USA.
Recognized as Phase 1 clinical trial experts, we operate over 200 beds, and have overseen more than 1,000 trials, of which 50% are first-in-human.
Our Australian Phase 1 facilities are in Melbourne and Brisbane, and our USA Phase 1 facility is in Minneapolis.
All three clinics are strategically co-located within leading medical, research and biotech precincts; the Alfred Hospital in Melbourne, the Royal Brisbane and Women’s Hospital in Brisbane, and Medical Alley in Minneapolis.
These precincts provide Nucleus Network with unique access to highly specialized ancillary services for the conduct of complex Phase 1 clinical trials. We have extensive experience in both biologic and small molecule products across most therapeutic areas.
As early phase specialists, we offer first-in-human study expertise, as well as rapid start clinical pharmacology studies. We are Australia’s premier Phase 1 trial facility and are one of the very few specialized units capable of delivering patients for hepatic and renal clinical trials in the USA.
Together with our clients, we are fulfilling our purpose of "Advancing medicine, improving lives."
.png)
SRM Centre
Embark on a journey of discovery and progress with SRM-CCTR, a leading clinical trial and research facility dedicated to advancing healthcare through cutting-edge studies. Our commitment to excellence has earned us the trust of the world's leading pharmaceutical companies and premier clinical research organizations. With state-of-the-art facilities, unwavering quality, meticulous selection processes, and a team of experts, SRM-CCTR is your dependable partner for transformative clinical research. We are thrilled to announce that SRM-CCTR has received approval from the Indian Council for Medical Research (ICMR) to conduct Phase 1 drug trials. This recognition underscores our dedication to pushing the boundaries of medical research and contributing to the development of ground breaking therapeutic
Visit Website.png)
Fenix Biosciences
Fenix Innovation Group and Pharmaron have partnered to propel biotech breakthroughs, now delivering comprehensive drug development and commercialisation services in Singapore and beyond. With expertise spanning cannabinoid-based therapies, neuroinflammatory treatments, orphan diseases, AI-powered medical devices, and veterinary care, combined with world-class capabilities in R&D, process chemistry, and scalable manufacturing, this partnership offers end-to-end solutions across every stage of the biotech journey. From discovery to regulatory approval, manufacturing, and market success, Fenix-Pharmaron provide a seamless pathway to bring groundbreaking therapies to patients faster. As Singapore cements its place as a life sciences powerhouse, Fenix-Pharmaron are leading the charge—transforming bold ideas into real-world healthcare solutions.
Visit Website
Investment NSW
Investment NSW is an agency under NSW Government with the mandate to deliver key priorities to build a strong economy, attract local and international investment and help NSW businesses find new export markets. Working across key industries, our aim is to reinforce NSW’s global position as a safe and attractive place to do business and accelerate investment in priority sectors such as Net Zero, Technology, Advanced Manufacturing, International Education, Med Tech and Life Sciences, Agri-business and Defence and Aerospace. NSW is open for business. Large or small, international or domestic, now is the time for investors to capitalise on all the state has to offer. We can help you start your business or grow your business. One of our main drivers is to act as a single point of entry for private sector proposals for working with the NSW Government and a concierge service that guides investors where they need to be.
Visit WebsiteExhibition & Networking
.png)
Accmed
ACCMED serves as a global technology partner in the domain of clinical trials. By fully leveraging the advanced capabilities of AI and cloud technology, we are driving a revolutionary change and accelerating the development of medical products. We provide an extensive and integrated solution suite, comprising Supply AI, Accmed-IRT, Accmed-eCOA, and Accmed-EDC. These solutions are built to optimize the complex clinical trial supply chains, enable informed decision - making, simplify operational processes, and elevate data reliability. Through strategic partnerships with us, our clients can achieve swifter outcomes and promptly bring innovative and life - transforming treatments to patients, thereby contributing significantly to the advancement of healthcare.
Visit Website.png)
Akesa
Established in 2014, Akesa is an end-to-end provider of clinical trial supplies and services.
With headquarters in Melbourne, Australia, Akesa boasts global reach with local APAC expertise. We work alongside sponsors, CROs, research institutions, clinical trial sites and CDMOs to project manage the sourcing of finished products from validated suppliers and directly from manufacturers including:
- comparators,
- combination therapies, and
- standard-of-care medications.
Partner with Akesa to unlock extensive market intelligence, specialised clinical trial project management expertise and deep connections with manufacturers for a customised solution to your clinical study.
Additionally, Akesa offers services including labelling, storage and distribution direct-to-site or direct-to-patient, and on-demand site-based sourcing for seamless supply of clinical trial medicines for sponsors, hospital pharmacies and sites.
.png)
Catalent
Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries. Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
Visit Website
ALMAC
Almac Clinical Services have been partnering with clients for 30+ years, we set the standard for developing effective supply chain strategies that ensures our sponsors can overcome their unique challenges and deliver supply continuity to patients wherever they are in the world. We have a range of tools and services to help you achieve this, from forecasting/inventory management, supply chain strategy to global logistics management, end-to-end temperature solutions, IRT set-up and strategy, direct to patient distribution and pharmacy services alongside our clinical packaging and labelling facilities. When you partner with Almac you are partnering with experts who Supply With CareTM
Visit WebsiteProgramme & Showcase
No items found.
Foundation
No items found.
Media & Publicity
Want to Sponsor This Event?
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Pre Conference Workshops
Visit the workshop page to view more content.
No items found.
Co-Located Events
Visit the event page to view more content.
Frequently Asked Questions
How can I stay updated on event details and announcements?
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
What can I expect to learn and explore during the event?
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
What safety measures will be in place to ensure the safety of attendees?
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Is there a cancellation or refund policy if I can't attend after registering?
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
Can I submit a presentation to be a speaker at this event?
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
What type of professionals benefit most from attending?
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
What advantages does this conference offer participants?
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Are there networking opportunities or special events planned?
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Are there sponsorship opportunities for this event?
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
How can I register for the event?
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Be a Part of This Event!
Don't miss out on unique networking, speaking and sponsorship opportunities.